Matinas BioPharma Holdings, Inc. (MTNB) stock
MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)
Close on Nov 18, 2026Market cap $13.37MP/E –Yield –
Matinas BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Matinas BioPharma's enterprise value was $5.20M on Nov 11, 2026, against $60.95M a year earlier. Over the last 5 years it ranged from $5.20M to $3.22B, with a median of $518.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.20M | -88.8% |
| 2025 | Dec 31, 2025 | $46.43M | +65.1% |
| 2024 | Dec 31, 2024 | $28.12M | -95.9% |
| 2023 | Dec 29, 2023 | $686.34M | -56.9% |
| 2022 | Dec 30, 2022 | $1.59B | -50.6% |
| 2021 | Dec 31, 2021 | $3.22B | -19.4% |
| 2020 | Dec 31, 2020 | $4.00B | -27.9% |
| 2019 | Dec 31, 2019 | $5.54B | +540.3% |
| 2018 | Dec 31, 2018 | $865.27M | -46.2% |
| 2017 | Dec 29, 2017 | $1.61B | +32.9% |
| 2016 | Dec 30, 2016 | $1.21B | – |
See a number that looks wrong?